Bayer investing in Toronto-based stem-cell research company – The Globe and Mail
|
Bayer investing in Toronto-based stem–cell research company
The Globe and Mail Drug maker Bayer AG and biotech venture-capital firm Versant Ventures are investing $225-million to create a Toronto-based stem–cell research company, a move with the potential to establish Canada as a global centre for the commercialization of … Bayer, Versant Mount New Stem-Cell Venture — WSJ – NASDAQ.com |
